AAIQ   The Association of Allergists and Immunologists of Québec

Oral immunotherapy for the treatment of food allergies


Résumé

Oral immunotherapy (OIT) is a form of immunotherapy designed to treat food allergies. Contrary to subcutaneous immunotherapy (injections) or sublingual (oral administration of a liquid suspension of tablet), OIT consists of the direct ingestion of a food, in precisely measured amounts following a set calendar. This therapy starts at very small doses, below the threshold of reaction of the patient, and slowly increases until a normal portion of the food is ingested. Once at this maintenance dose, the patient must continue to ingest the food on a regular basis in order to maintain protection.

The 3 potential benefits of oral immunotherapy are:

  1. To protect from reactions on an accidental basis
  2. To reintegrate the food in the normal diet
  3. To definitively resolve the allergy (sustained tolerance)

The success rates for the 2 former objectives are approximately 80% in certain studies and can exceed 90% in private clinics, possibly because of the greater flexibility of protocols. Sustained tolerance (the 3rd objective), which is defined by persistent tolerance to the food in question after a prolonged discontinuation of daily doses, may be possible after several years of treatment in certain patients.

In a recent survey in the United States, 13% of allergists were reported to practice oral immunotherapy. The University Hospital Centre of Sainte-Justine (CHU Sainte-Justine) is now happy to offer a new service treating food allergies with oral immunotherapy outside of a research context.

For additional information, please consult the document in detail (published 2016, French version).

__________________________

François Graham MD, MSc, FRCPC and Philippe Bégin MD, PhD, FRCPC

(translation: Andrew Moore, MD, FRCPC)

revised 9/11/2017

In detail